Ignite Creation Date:
2024-05-06 @ 2:16 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04260009
Status:
WITHDRAWN
Last Update Posted:
2020-03-05
First Post:
2020-01-22
Brief Title:
Pharmacokinetics Safety and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK Anaplastic Large Cell Lymphoma Inflammatory Myofibroblastic Tumors or Other Solid Tumors
Sponsor:
Takeda
Organization:
Takeda
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-22
First Submit QC Date:
February 5 2020
Study First Post Date:
2020-02-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-02
Last Update Post Date:
2020-03-05
Last Update Post Date Type:
ACTUAL